Nanovery is developing nanorobots to diagnose the world's deadliest diseases. Our nanorobots are added to blood samples. When they capture a cancer biomarker they light up, allowing point-of-care testing. As there is no need for high capital expenditure, our nanorobots are 10 times cheaper. The whole process is also more than 100 times faster - a matter of one or two hours rather than weeks - as there is no need for complex lab protocols which require bioinformaticians to analyse the data.